La Jolla, CA, United States of America

Elise Landais

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: International Aids Vaccine Initiative. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elise Landais. Retrieved from https://idiyas.com/inventor/elise-landais

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elise Landais: Innovator in HIV Research

Introduction

Elise Landais is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of HIV research, particularly through her innovative work on antibodies. Her dedication to advancing medical science is evident in her patent portfolio.

Latest Patents

Elise holds a patent for "Anti-HIV Antibodies," which showcases her commitment to developing solutions for one of the world's most pressing health issues. This patent represents a crucial step in the fight against HIV, highlighting her role as a key innovator in this area.

Career Highlights

Elise Landais is associated with the International Aids Vaccine Initiative, where she collaborates with other experts to further research and development in HIV prevention. Her work at this organization underscores her commitment to public health and innovation.

Collaborations

Elise collaborates with Devin Sok, a fellow researcher, to enhance the effectiveness of their projects. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Elise Landais is a trailblazer in the field of HIV research, with a focus on developing innovative solutions to combat the virus. Her contributions through her patent and work at the International Aids Vaccine Initiative are vital to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…